Information Request Form

Section:	Main.PNEUMOLOGY.Asthma.Treatment.Steroids.Mometasone Furoate..NonGeneric Mometasone Furoate.Patent..Claims.Claim 1: CorticoSteroid-Responsive.Disease of the Lower Airway Passage.Treat. Method: Adm. as Initial or.Maintenance Therapy to the Surfaces.of Passages > Once Daily Non-.Systemically BioAvailable Amount of.Aerosolized Particles of Mometasone.Furoate. Claim 2: Disease:.Allergic or Inflammatory Disease..Claim 3: Disease: Asthma. Claims.10,11: Daily Amount=10-2000 &.50-1000 micrograms resp. Claims.12,13: Adm. Once Daily. Claim 14:.Adm.: Oral Inhalation. Claim 15:.Deliv.: Pressurized Aerosol Metered.Dose Inhaler. Claim 16: Deliv.:.Dry Powder Inhaler. Claim 29:.Mometasone Furoate is Admixed.with Lactose. Patent Assignee
Code:	58806
Product:	USA. S
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:	PATENT ASSIGNEE PATENT INVENTORS PATENT NUMBER PATENT PARENT CASE TEXT
* If you are not linked to any company or organization complete at least this field